{
  "docId": "019dd923-622c-750b-8b99-9ee2a1e788fb",
  "docSlug": "1233d0b05ad9",
  "documentTitle": "PROCEPT BioRobotics Corporation (PRCT)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-01-16 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 99,
  "pageCount": 100,
  "prevPage": 98,
  "nextPage": 100,
  "slideType": "preempt_rebuttal",
  "function": "preempt_rebuttal",
  "density": "overcrowded",
  "nDataPoints": 33,
  "notes": "Includes a table of historical and projected financials with a highlighted 'Period of massive uncertainty'.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "data_table",
    "bullet_list",
    "callout_box",
    "comparison_table",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-9ee2a1e788fb/99",
  "deckHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb#slide-99",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.61,
        "y": 0.44
      },
      "kind": "callout",
      "text": "Period of massive uncertainty",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6929743d-bceb-4342-8044-09071a032ea7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "To reach any meaningful level of profitability, an investor in Procept must assume the Company will: More than triple revenue; Either be used for nearly 175,000 BPH procedures... or hit a home run in a prostate cancer application.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-ee36-760b-929e-0d2d2d2b6d67",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.96,
        "x": 0.02,
        "y": 0.48
      },
      "kind": "list",
      "text": "To reach any meaningful level of profitability, an investor in Procept must assume the Company will: More than triple revenue; Either be used for nearly 175,000 BPH procedures...; Take massive share...; Suffer no price compression...; Fend off numerous emerging competitive alternatives; Achieve dramatic improvements in operating leverage...",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d022023f-d6f2-4355-9c3e-4fdc6e8a7050",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "GAAP Net Income",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-ee36-760b-929e-15266aad88a7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.96,
        "x": 0.02,
        "y": 0.17
      },
      "kind": "paragraph",
      "text": "At least one sell-side analyst covering Procept, and realistically any DCF-based valuation, depends heavily on “best case scenarios” of the Company’s performance at points in time 5- or 10-years in the future.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "359a5a69-ca56-4d39-8ee4-1d1d05da2f1c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"I've practiced urology for 30+ years. You could fill dumpsters w BPH solution technologies/companies. Nobody will remember this company in 3-5 years.\" — Urodoc on Seekingalpha, 9/6/24",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-ee36-760b-929e-1289f86832f9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.4,
        "x": 0.02,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: S&P Capital IQ, Urodoc on Seekingalpha, Spruce Point research",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cf29ad8d-7821-43a8-b5c5-786e57d3f723",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.96,
        "x": 0.02,
        "y": 0.28
      },
      "kind": "table",
      "text": "Procept Historical Financials and Long-Term Street Consensus Projections",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8ce2e7f0-add1-4c34-9f23-9368e506a940",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.23,
        "w": 0.96,
        "x": 0.02,
        "y": 0.71
      },
      "kind": "table",
      "text": "Urologist testimonials regarding Procept's market position and sales performance.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bf1583a9-f547-48e4-b351-72565fd8f406",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.68,
        "x": 0.28,
        "y": 0.03
      },
      "kind": "title",
      "text": "Realistically, We Don't Believe Procept Will Achieve The Street's Profit Expectations",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2b485a81-a280-4adf-88f7-66e91a5b0116",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Scenario planning",
      "slug": "scenario-planning",
      "agent": null,
      "layer": "block",
      "matchId": "192afe76-1d7c-4844-8ea9-6b5e2466d0f1",
      "evidence": "keyword-coverage: scenario, uncertainty",
      "confidence": 0.2
    }
  ],
  "frameworks": [
    {
      "name": "preempt_rebuttal",
      "slug": null,
      "matchId": "1c698678-0e87-4426-88b7-87f9fa026c1d",
      "evidence": "Critiques Street consensus projections and provides counter-arguments.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}